This NDC is on FDA's drug shortage list (posted Jul 14, 2023)

Product Information

LISDEXAMFETAMINE 30 MG TB CHEW is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $3.3552 per EA under NDC 57664008588. Its NADAC has been published 140 times since Dec 20, 2023.

FDA first approved this application on Aug 25, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LISDEXAMFETAMINE 30 MG TB CHEW

LISDEXAMFETAMINE DIMESYLATE
$3.3552per EA
DEA Schedule CII

Strength

30 mg/1

NDC

57664008588

Classification

Generic

Dosage Form

TABLET, CHEWABLE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

LISDEXAMFETAMINE DIMESYLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA214134

FDA Approved

8/25/2023

TE Code

AB

On Market Since

8/25/2023

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for LISDEXAMFETAMINE 30 MG TB CHEW has been published 140 times since Dec 20, 2023, and over the history we have for it it has declined 57.0%. The table below summarizes its recorded NADAC range and movement.

Current price$3.3552 per EA
All-time high$9.4441 (Apr 10, 2024)
All-time low$3.3552 (Aug 19, 2026)
52-week high$7.3210
52-week low$3.3552
Median price$7.3921
Average price$7.0516
Largest weekly change+22.9% (Mar 20, 2024)
Weeks tracked140
Tracking sinceDec 20, 2023

Price History

1W

-0.1%

1M

-0.1%

3M

-21.8%

6M

-41.9%

1Y

-52.8%

3Y

N/A

5Y

N/A

All

-57.0%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LISDEXAMFETAMINE 30 MG TB CHEW?

The current National Average Drug Acquisition Cost (NADAC) for LISDEXAMFETAMINE 30 MG TB CHEW, manufactured by Sun Pharmaceutical Industries Inc., is $3.3552 per EA (NDC 57664008588), effective Aug 19, 2026.

How has the price of LISDEXAMFETAMINE 30 MG TB CHEW changed over time?

Over the history we have for it, the NADAC for LISDEXAMFETAMINE 30 MG TB CHEW has declined 57.0%. It has been tracked across 140 weekly CMS publications since Dec 20, 2023.

What are the highest and lowest recorded NADAC prices for LISDEXAMFETAMINE 30 MG TB CHEW?

Since Dec 20, 2023, the NADAC for LISDEXAMFETAMINE 30 MG TB CHEW has ranged from a low of $3.3552 (Aug 19, 2026) to a high of $9.4441 (Apr 10, 2024), with a median of $7.3921 per EA.

Are there cheaper alternatives to LISDEXAMFETAMINE 30 MG TB CHEW?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as LISDEXAMFETAMINE 30 MG TB CHEW in a comparable dosage form, but none are currently priced below it.

Who manufactures LISDEXAMFETAMINE 30 MG TB CHEW?

LISDEXAMFETAMINE 30 MG TB CHEW (NDC 57664008588) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.

Is LISDEXAMFETAMINE 30 MG TB CHEW in shortage?

Yes — NDC 57664008588 is currently listed in FDA's drug shortage database (posted Jul 14, 2023).